Childhood malignant diseases: which is the carnitine's role?

J Pediatr Hematol Oncol. 2007 May;29(5):291-2. doi: 10.1097/MPH.0b013e318055644b.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carnitine / administration & dosage
  • Carnitine / metabolism*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*

Substances

  • Carnitine